Regulation of pharmaceutical innovation : The 1962 amendments

The production of these effects would not necessarily tell us anything about the costs and benefits of the 1962 amendments. The costs and benefits would depend on the value of the particular drugs kept off the market by the amendments and the value of the information on new drugs generated by more e...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Peltzman, Sam
Formaat: Boek
Taal:Undetermined
Gepubliceerd in: Washington American Enterprise Institute for Public Policy Research 1974
Onderwerpen:
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
Thư viện lưu trữ: Trung tâm Học liệu Trường Đại học Cần Thơ